CHATSWORTH, Calif.--(BUSINESS WIRE)--CHAD Therapeutics, Inc. (AMEX:CTU) today reported financial results for the fourth quarter and fiscal year ended March 31, 2007, and provided an update on its strategic direction and new product development programs.
